Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | SGR-3515 |
| Synonyms | |
| Therapy Description |
SGR-3515 inhibits WEE1 and PKMYT1, which potentially induces apoptosis in tumor cells and inhibits tumor growth (Cancer Res (2025) 85 (8_Supplement_1): 3025, Cancer Res (2025) 85 (8_Supplement_1): 358). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| SGR-3515 | SGR 3515|SGR3515 | PKMYT1 Inhibitor 4 WEE1 Inhibitor 8 | SGR-3515 inhibits WEE1 and PKMYT1, which potentially induces apoptosis in tumor cells and inhibits tumor growth (Cancer Res (2025) 85 (8_Supplement_1): 3025, Cancer Res (2025) 85 (8_Supplement_1): 358). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06463340 | Phase I | SGR-3515 | Study of SGR-3515 In Participants With Advanced Solid Tumors. | Recruiting | USA | CAN | 0 |